Every AI newsletter, investors ask on the investor interaction platform: has the company’s covid-19 testing reagent obtained the qualification of FDA or sold?
Chempartner Pharmatech Co.Ltd(300149) (300149. SZ) said on the investor interaction platform on January 21 that the company has provided R & D services for customers’ reagents and methods for covid-19 virus serological detection, but it is inconvenient for the company to disclose the progress of customers’ products without the consent of customers.
